Correlation Between Enliven Therapeutics and Dogwood Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enliven Therapeutics and Dogwood Therapeutics,, you can compare the effects of market volatilities on Enliven Therapeutics and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Dogwood Therapeutics,.

Diversification Opportunities for Enliven Therapeutics and Dogwood Therapeutics,

-0.35

Correlation Coefficient

Enliven Therapeutics  Dogwood Therapeutics,

Very good diversification

The 3 months correlation between Enliven and Dogwood is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Dogwood Therapeutics, go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Dogwood Therapeutics,

Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Dogwood Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 15.88 times less risky than Dogwood Therapeutics,. The stock trades about -0.04 of its potential returns per unit of risk. The Dogwood Therapeutics, is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  272.00  in Dogwood Therapeutics, on December 21, 2024 and sell it today you would earn a total of  401.00  from holding Dogwood Therapeutics, or generate 147.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

Enliven Therapeutics  vs.  Dogwood Therapeutics,

Enliven Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enliven Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Dogwood Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dogwood Therapeutics, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dogwood Therapeutics, showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enliven Therapeutics and Dogwood Therapeutics,

The main advantage of trading using opposite Enliven Therapeutics and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.

The idea behind Enliven Therapeutics and Dogwood Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.